GUJTHEM
Gujarat Themis Biosyn Limited
Pharmaceuticals
Share price
₹353
Market cap
₹4,578 Cr
1Y return
▼ 16%
A pharmaceutical manufacturer incorporated in 1981, Gujarat Themis Biosyn produces finished Active Pharmaceutical Ingredients through advanced fermentation-based processes. The company specializes in biosynthetic drug compounds for both domestic and international markets. Its proprietary fermentation expertise, vertical integration in API manufacturing, and focus on complex molecule production distinguish it within India's competitive pharmaceutical sector.
Investors holding Gujarat Themis Biosyn Limited
Recent moves 3
Quant Mutual FundIncreased
Quant Mutual Fund increased its stake in Gujarat Themis Biosyn from 1.15% to 7.47%, acquiring 84,74,577 shares to cross the 5% disclosure threshold.
Read more
Bank of India Mutual FundNew position
Bank of India Mutual Fund added over 0.63% of Gujarat Themis Biosyn Limited and now holds 1.63%, or 21,18,645 shares.
Read more
Kotak Mahindra Life InsuranceNew position
Kotak Mahindra Life Insurance added over 1.17% of Gujarat Themis Biosyn during the quarter and now holds 2.17%, or 28,24,859 shares.
Read more
Track the whales in Gujarat Themis Biosyn Limited
Get alerted the moment a top investor buys or sells.
Start 7 days for ₹1